serology showed no evidence of recent viral or mycoplasmal infection. Serum IgA was slightly reduced at 1.17 g/l (normal 1.25-4 .25 g/l) and the IgM was 0.47 g/l (normal 0.5-1.75 g/l), with a normal IgG. A chest X-ray was normal. Spinal fluid examination showed a protein of 0.7 g/l (normal up to 0.45 g/l), glucose 4.8 mmol/l, with no white cells, and no growth on culture. Nerve conduction studies showed motor nerve conduction of the median nerve was 30 m/second with a distal motor latency of 4.7 milliseconds (normal, up to 4.2 millseconds). F responses were unobtainable. Distal sensory nerve conduction velocity of median nerve was 29 m/second, the sensory action potential being reduced at 1.5 jLV. The extensor digitorum muscle was denenervated and motor conduction along the peroneal nerve could not be obtained. Motor latency from the capitulum fibulae to the tibialis anterior was slightly prolonged, but the M wave was markedly decreased (0.1 mV).
She received a 5-day course of intravenous immunoglobulin (Venoglobulin, Alpha Pharmaceuticals) at 0.4 g/ kg/day, and steadily improved. After 3 Two points emerge from this patient's tragic outcome. Firstly, severe abdominal or back pain may be the earliest symptoms of severe systemic involvement in varicella. Any delay in treatment diminishes the effectiveness of acyclovir and these symptoms should be indications for the prompt intravenous administration of acyclovir which may be effective even in the presence of DIC. Secondly, anti-epileptic drugs can cause thrombocytopenia, bleeding disorders, and immune defects all ofwhich could predispose to the development of varicella with haemorrhagic complications. The occurrence of varicella in patients on anti-epileptic drugs may therefore be an indication for the early use of acyclovir.
